0001683168-18-002413.txt : 20180820 0001683168-18-002413.hdr.sgml : 20180820 20180820075056 ACCESSION NUMBER: 0001683168-18-002413 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180820 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180820 DATE AS OF CHANGE: 20180820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chineseinvestors.com, Inc. CENTRAL INDEX KEY: 0001459482 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] IRS NUMBER: 352089868 STATE OF INCORPORATION: IN FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54207 FILM NUMBER: 181027154 BUSINESS ADDRESS: STREET 1: 227 W. VALLEY BLVD. SUITE 208A CITY: SAN GABRIEL STATE: CA ZIP: 91776 BUSINESS PHONE: 800-958-8561 MAIL ADDRESS: STREET 1: 227 W. VALLEY BLVD. SUITE 208A CITY: SAN GABRIEL STATE: CA ZIP: 91776 8-K 1 chinesinvestors_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):

August 20, 2018

____________________________

 

ChineseInvestors.com, Inc.

(Exact name of registrant as specified in its charter)

 

____________________________

 

 

Indiana   000-54207   35-2089868
(State of Organization)   (Commission File Number)   (I.R.S. Employer Identification Number)
         
227 W. Valley Blvd. #208A, San Gabriel, CA       91776
(Address of principal executive offices)       (Zip Code)

 

(626) 589-2468

(Registrant’s telephone number, including area code)

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

☐ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

Item 8.01 Other Events

 

ChineseInvestors.com, Inc. announces that its wholly owned foreign enterprise in China, CBD Biotechnology Co. Ltd., has launched a two-tier, direct selling initiative to accelerate its CBD sales into China. In addition, the Company has appointed marketing expert Mr. Fengxian Xie as President of its CBD Community Center.

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit 99.1          Press Release dated August 20, 2018

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Date: August 20, 2018

 

ChineseInvestors.com, Inc.

 

By: /s/ Wei Wang                           

Name: Wei Wang

Title: Chief Executive Officer

EX-99.1 2 chinese_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

ChineseInvestors.com, Inc.’s wholly owned foreign enterprise, CBD Biotechnology Co Ltd., Launches Innovative CBD Two-Tier Direct Selling Initiative to Accelerate Sales in China

 

SAN GABRIEL, CA (August 20, 2018) - ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (“CBD Biotech”), has launched a two-tier, direct selling initiative to accelerate its CBD sales into China. In addition, the Company has appointed marketing expert Mr. Fengxian Xie as President of its CBD Community Center, effective immediately. The goal of the CBD Community Center initiative is to establish a new, effective marketing channel to further stimulate demand for CBD Biotech’s innovative CBD-infused skin care products.

 

Mr. Xie is an exemplary addition to the CBD Biotech management team with nearly 20 years of marketing experience with Hainan Coconut Island Group Co. Ltd., a Chinese A-listed company, and its subsidiary Zhejiang Marketing Company. Mr. Xie’s accomplishments include tripling sales in the Zhejiang region, from 2.1 million CNY to 7.6 million CNY within a year of joining Zhejiang Marketing Company.

 

As the President of the CBD Community Center, Mr. Xie will spearhead growing customer awareness of CBD Biotech’s inaugural line of hemp-infused skin care products, CBD Magic Hemp Series and its luxury line, Live Oxygen. In addition, he will manage building a community-centered around a direct selling team through seminars and expos designed for both business-to-business and business-to-customer sales opportunities. Members of the CBD Community Center will be compensated for product sales and will also receive stock-based performance bonuses. “We believe we are building the first Chinese CBD marketing community that offers our members the opportunity to become invested in the Company. Our efforts in advancing the CBD Community Center will involve a twofold mission: to educate the Chinese community about the benefits of hemp-infused skin care and increase product sales. We are confident that with Mr. Xie’s experience and proven track record, he is the perfect candidate to lead the development of this direct selling initiative,” says ChineseInvestors.com, Inc. CEO Warren Wang.

 

Mr. Xie stated, “I am honored to have been chosen to take the lead in building this CBD direct selling community. ChineseInvestors.com has a tremendous competitive advantage in that we are one of the first companies to offer hemp-infused skin care products in China. I look forward to expanding the community’s reach to every city within China.”

 

The CBD Community Center is located at Floor 27, A Unit, Industrial Investment Building, NO.18 North Caoxi Road, Shanghai, China.

 

About ChineseInvestors.com (OTCQB: CIIX) 

 

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.

 

For more information visit ChineseInvestors.com

 

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

 

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

 

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom;

 

https://www.facebook.com/Chineseinvestors.com.english

 

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn

 

Contact:

ChineseInvestors.com, Inc.

227 W. Valley Blvd, #208 A

San Gabriel, CA 91776

www.Chinesefn.com

www.Chinesehempoil.com

 

Investor Relations:

Alan Klitenic

+1.214.636.2548

 

Corporate Communications:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com